SBC Medical Group Holdings Incorporated

SBC Industrials Consulting Services

SBC Medical Group Holdings Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $173.6 million, down 15.5% from fiscal 2024.

Revenue
+13.4%
EPS
+400.0%
Free cash flow
+396.1%
Total debt
+420.7%

Quarter to June 2026, against a year earlier

4.89 0.13 −2.59%
Market cap
$516.3M
P/E
10.7×
Fwd P/E
11.3×
Dividend yield
—
F-score
3/9
Altman Z
4.74
Beneish M
−1.96
Dividend safety
n/a

Insider Decisions last twelve months

Sold, $m 20.15
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell — — — 1 2 — — — — — — —
Insider Ownership 81.51%

Capital & Financial Ratios $m

Size
Market Cap 516.30
Revenue ttm 175.17
Net income ttm 49.60
Free cash flow ttm 66.45
Net debt Q (146.79)
Valuation
P/E 10.68
Forward P/E 11.30
Price / sales 2.94
Forward P/S Powerpack
Price / FCF 7.75
Price / book 1.84
Financial health
Current ratio Q 3.31 (at or above 1.5: strong)
Debt / equity Q 0.14 (at or below 0.5: strong)
Interest coverage Q 147.44
Growth
Revenue growth Q +13.44% (above 0%: growing)
Operating income growth Q +30.28% (above 0%: growing)
EPS, this year −8.27% (below 0%: weak)
EPS, next year A +13.93%
Revenue, next year A +10.02% (at or above 10%: strong)
EPS, past 5 yrs —
EPS, next 5 yrs A +1.43%

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

P/E against its own 10 years 40.15%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 103 125 164 185
Receivables 44 41 40 51
Inventory 3 1 3 3
Other 6 6 13 14
166 184 231 259
2023 2024 2025 Q'26
Payables 27 15 18 24
ST’ Debt 0 0 9 12
Other 25 13 7 5
92 61 61 78

Compound Annual Growth %

10y 5y 3y
Sales — — —
Cash Flow — — 0.00%
Earnings — — 351.81%
Book Value — — 0.00%

Earnings Trends EPS, adjusted, against the consensus

EPS $

Mar Jun Sep Dec Year
’26 0.11 0.10 — — —
’25 0.21 0.02 0.12 0.14 0.50
’24 0.20 0.20 0.03 0.06 0.48
’23 0.21 0.16 0.09 0.15 0.41
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 43 49 — — —
’25 47 43 43 40 174
’24 55 53 53 44 205
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 9 23 — — —
’25 2 (8) (21) 52 25
’24 4 19 5 (7) 21
’23 0 (1) 24 28 51
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 9 22 — — —
’25 1 (7) (20) 56 30
’24 3 18 4 (8) 17
’23 0 (1) 28 21 48
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Jun ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue — — — — — — — 194 205 174 175 (5.3%) 191 210 227 +9.4%
Gross margin, % — — — — — — — 70.94 75.97 73.32 71.85 +2.4 pt
EBT — — — — — — 1 74 73 82 75 +367.9%
EBT margin, % — — — — — — 0.00 38.02 35.76 47.27 43.09 +47.3 pt
Net income — — — — — — 1 39 47 51 50 +352.0%
Per share, $
Per share, $ Revenue — — — — — — 0.00 2.05 2.13 1.69 1.71 n/m
Earnings — — — — — — 0.16 0.41 0.48 0.50 0.47 +45.3%
Cash flow — — — — — — (0.17) 0.54 0.21 0.24 0.61 n/m
Capex — — — — — — 0.00 (0.03) (0.04) 0.05 0.04 n/m
Free cash flow — — — — — — (0.17) 0.50 0.18 0.29 0.65 n/m
Book value — — — — — — (1.25) 1.53 2.02 2.56 2.73 n/m
Shares, m — — — — — — 3 94 97 103 103 +237.3%
Valuation, ×
Valuation, × P/E — — — — — — — 17.56 11.44 8.80 10.68 12.6
P/S — — — — — — — 0.00 2.61 2.56 2.94 1.7
P/B — — — — — — — 7.07 2.75 1.69 1.84 3.8
EV/Sales — — — — — — — 0.00 2.04 1.86 2.10 1.3
EV/FCF — — — — — — — 18.30 24.36 10.84 5.54 17.8
Cash, $m
Cash, $m Operating cash flow — — — — — — 0 51 21 25 63 n/m
Capex — — — — — — — (3) (3) 5 4 n/m
Free cash flow — — — — — — 0 48 17 30 66 n/m
Balance, $m
Balance, $m Working capital — — — — — — 0 73 123 170 181 +928.8%
Net debt — — — — — — 0 (90) (118) (121) (147) +529.5%
Shareholders’ equity — — — — — — (3) 144 195 263 280 n/m
Returns, %
Returns, % ROA — — — — — — 0.00 20.79 17.76 15.77 13.58 +15.8 pt
ROIC — — — — — — 0.00 81.85 57.38 29.67 30.71 +29.7 pt
ROE — — — — — — 0.00 56.06 27.51 22.25 18.69 +22.3 pt
People
People Employees — — — — — — 2 2 863 863 — +655.7%
Revenue/emp, $m — — — — — — 0.00 96.77 0.24 0.20 — n/m
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026 · fundamentals updated 26 Oct 2026

SBC Medical Group Holdings Incorporated vs peers in Consulting Services (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
HURN Huron Consulting Group Inc. $2.8B 25.7× 25.7× +11.37% (above 0%: growing) +1.98% (above 0%: growing) −42.44% (below 0%: shrinking) 32.24% 11.97% Compare
ICFI ICF International, Inc. $1.7B 17.8× 16.2× +1.09% (above 0%: growing) +37.21% (above 0%: growing) −29.12% (below 0%: shrinking) 38.08% 0.00% Compare
CRAI Charles River Associates $1.3B 24.9× 24.2× +15.61% (above 0%: growing) +27.49% (above 0%: growing) +103.95% (above 0%: growing) 29.10% 11.12% Compare
SBC SBC Medical Group Holdings Incorporated $516.3M 10.7× 11.3× +13.44% (above 0%: growing) +400.00% (above 0%: growing) +396.07% (above 0%: growing) 73.14% 38.55%
ROMA Roma Green Finance Limited $373.5M — — — — +20.80% (above 0%: growing) — — Compare
PPHC Public Policy Holding Company, Inc. $342.7M — (loss-making) — (loss-making) +7.32% (above 0%: growing) n/m −69.72% (below 0%: shrinking) 21.77% (7.45%) Compare
FORR Forrester Research, Inc. $165.6M — (loss-making) — (loss-making) −8.68% (below 0%: shrinking) n/m −197.82% (below 0%: shrinking) 59.95% 2.77% Compare
EGG Enigmatig Limited $143.8M — — — — — — — Compare
RGP Resources Connection, Inc. $91.3M — (loss-making) — (loss-making) −18.42% (below 0%: shrinking) n/m −140.54% (below 0%: shrinking) 37.38% (7.45%) Compare
Median of peers $358.1M 24.9× 24.2× +4.21% +27.49% −42.44% 34.81% 1.39%

All 23 Consulting Services stocks →

Pay and ownership Proxy statement filed 28 May 2026

Ownership

Directors and executive officers, together 81.70%
Yoshiyuki Aikawa 81.70%
Aikawa Equity Management Co., Ltd. 5.20%
Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

SBC Medical Group Holdings Incorporated (SBC) Latest News

14 Aug

8 Apr

27 Mar

13 Mar

stockrow.com/SBC · Data as of Oct 26, 2026 · For information only; not investment advice. · © 2026 stockrow.com